Rho-kinase/ROCK is Involved in Cytokinesis Through the Phosphorylation of Myosin Light Chain and Not Ezrin/radixin/moesin Proteins at the Cleavage Furrow
Overview
Affiliations
The small GTPase Rho and one of its targets, Rho-kinase (also termed ROK or ROCK), are implicated in various cellular functions including stress fiber formation, smooth muscle contraction, tumor cell invasion and cell motility. We have previously reported that Rho-kinase accumulates at the cleavage furrow during cytokinesis in several cultured cells. Here, using Rho-kinase inhibitors, Y-27632 and HA1077, we found that Rho-kinase is responsible for the phosphorylation of myosin regulatory light chain at Ser19 in the cleavage furrow during cytokinesis. On the other hand, phosphorylation of ezrin/radixin/moesin (ERM) proteins at the cleavage furrow was enhanced by the addition of the above Rho-kinase inhibitors. Treatment with Y-27632 strongly enhanced the accumulation of Rho-kinase but not RhoA and citron kinase at the cleavage furrow. Furthermore, the furrow ingression in cytokinesis was significantly prolonged in the presence of Y-27632. These results suggest that Rho-kinase is involved in the progression of cytokinesis through the phosphorylation of several proteins including myosin light chain at the cleavage furrow.
Control of spatio-temporal patterning via cell growth in a multicellular synthetic gene circuit.
Santorelli M, Bhamidipati P, Courte J, Swedlund B, Jain N, Poon K Nat Commun. 2024; 15(1):9867.
PMID: 39562554 PMC: 11577002. DOI: 10.1038/s41467-024-53078-8.
Matsuura Y, Kaizuka K, Inoue Y Int J Mol Sci. 2024; 25(8).
PMID: 38674111 PMC: 11050551. DOI: 10.3390/ijms25084526.
Martino J, Siri S, Calzetta N, Paviolo N, Garro C, Pansa M Elife. 2023; 12.
PMID: 37073955 PMC: 10185344. DOI: 10.7554/eLife.80254.
New Drugs and Therapies in Pulmonary Arterial Hypertension.
Shah A, Beckmann T, Vorla M, Kalra D Int J Mol Sci. 2023; 24(6).
PMID: 36982922 PMC: 10058689. DOI: 10.3390/ijms24065850.
Obligate role for Rock1 and Rock2 in adult stem cell viability and function.
Sambandam A, Storm E, Tauc H, Hackney J, Garfield D, Caplazi P Heliyon. 2023; 9(3):e14238.
PMID: 36950615 PMC: 10025895. DOI: 10.1016/j.heliyon.2023.e14238.